Adipose tissue stem cells: The great WAT hope

Trends in Endocrinology and Metabolism

Volumn 23, Issue 6, 2012, Pages 270-277

  Cawthorn, William P ^a   Scheller, Erica L ^a   MacDougald, Ormond A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCYTOSINE; FLUOROURACIL;

ADIPOGENESIS; ADIPOSE TISSUE; CANCER THERAPY; CARCINOGENESIS; CARCINOGENICITY; CELL FATE; EMBRYONIC STEM CELL; EXOSOME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE ENGINEERING; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE THERAPY; HUMANS; MODELS, ANIMAL; PARACRINE COMMUNICATION; PLURIPOTENT STEM CELLS; STEM CELLS;

EID: 84861664236     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.01.003     Document Type: Review

References (105)

1. Friedenstein A.J., et al. Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968, 6:230-247.
2. Pittenger M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
3. Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
4. da Silva Meirelles L., et al. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 2006, 119:2204-2213.
5. Zuk P.A., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
6. Halvorsen Y.D., et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng. 2001, 7:729-741.
7. Zuk P.A., et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13:4279-4295.
8. Cawthorn W.P., et al. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J. Lipid Res. 2011, 53:227-246.
9. Casteilla L., et al. Adipose-derived stromal cells: their identity and uses in clinical trials, an update. World J. Stem Cells 2011, 3:25-33.
10. Lindroos B., et al. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 2011, 7:269-291.
11. Gimble J.M., et al. Concise review: adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation. Stem Cells 2011, 29:749-754.
12. Brzoska M., et al. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem. Biophys. Res. Commun. 2005, 330:142-150.
13. Du Y., et al. Adipose-derived stem cells differentiate to keratocytes in vitro. Mol. Vis. 2010, 16:2680-2689.
14. Vossmerbaeumer U., et al. Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy 2009, 11:177-188.
15. Yang Z., et al. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch. Clin. Exp. Ophthalmol. 2010, 248:1415-1422.
16. Ferro F., et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am. J. Pathol. 2011, 178:2299-2310.
17. Li K., et al. Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev. 2010, 19:1267-1275.
18. Feng Z., et al. Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol. Dial. Transplant. 2010, 25:3874-3884.
19. Seo M.J., et al. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem. Biophys. Res. Commun. 2005, 328:258-264.
20. Banas A., et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007, 46:219-228.
21. Aurich H., et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009, 58:570-581.
22. Kim D.H., et al. Effect of partial hepatectomy on in vivo engraftment after intravenous administration of human adipose tissue stromal cells in mouse. Microsurgery 2003, 23:424-431.
23. Banas A., et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J. Gastroenterol. Hepatol. 2009, 24:70-77.
24. Chandra V., et al. Generation of pancreatic hormone-expressing islet-like cell aggregates from murine adipose tissue-derived stem cells. Stem Cells 2009, 27:1941-1953.
25. Chandra V., et al. Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS ONE 2011, 6:e20615.
26. Lin G., et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev. 2009, 18:1399-1406.
27. Kajiyama H., et al. Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice. Int. J. Dev. Biol. 2010, 54:699-705.
28. Sun N., et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15720-15725.
29. Sugii S., et al. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3558-3563.
30. Aoki T., et al. Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Eng. Part A 2010, 16:2197-2206.
31. Sugii S., et al. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat. Protoc. 2011, 6:346-358.
32. Lister R., et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011, 471:68-73.
33. Parameswaran S., et al. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency. Stem Cells 2011, 29:1013-1020.
34. Jia F., et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 2010, 7:197-199.
35. Oh H.J., et al. Recloned dogs derived from adipose stem cells of a transgenic cloned beagle. Theriogenology 2011, 75:1221-1231.
36. Qin Y., et al. Chromosomal instability of murine adipose tissue-derived mesenchymal stem cells in long-term culture and development of cloned embryos. Cloning Stem Cells 2009, 11:445-452.
37. Salgado A.J., et al. Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr. Stem Cell Res. Ther. 2010, 5:103-110.
38. Lopatina T., et al. Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS ONE 2011, 6:e17899.
39. Nakada A., et al. Regeneration of central nervous tissue using a collagen scaffold and adipose-derived stromal cells. Cells Tissues Organs 2009, 190:326-335.
40. Wrage P.C., et al. The neuro-glial properties of adipose-derived adult stromal (ADAS) cells are not regulated by Notch 1 and are not derived from neural crest lineage. PLoS ONE 2008, 3:e1453.
41. Miyahara Y., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 2006, 12:459-465.
42. Cai L., et al. IFATS collection: Human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009, 27:230-237.
43. Nakagami H., et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2542-2547.
44. Cai L., et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007, 25:3234-3243.
45. Kim J.M., et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res. 2007, 1183:43-50.
46. Garcia M.M., et al. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J. Sex Med. 2010, 7:89-98.
47. Huang Y.C., et al. The effect of intracavernous injection of adipose tissue-derived stem cells on hyperlipidemia-associated erectile dysfunction in a rat model. J. Sex Med. 2010, 7:1391-1400.
48. Puissant B., et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005, 129:118-129.
49. Yanez R., et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006, 24:2582-2591.
50. Niemeyer P., et al. Comparison of immunological properties of bone marrow stromal cells and adipose tissue-derived stem cells before and after osteogenic differentiation in vitro. Tissue Eng. 2007, 13:111-121.
51. Wolbank S., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007, 13:1173-1183.
52. Cui L., et al. Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Eng. 2007, 13:1185-1195.
53. DelaRosa O., et al. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng. Part A 2009, 15:2795-2806.
54. Yanez R., et al. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp. Cell Res. 2010, 316:3109-3123.
55. Najar M., et al. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng. Part A 2010, 16:3537-3546.
56. McIntosh K.R., et al. Immunogenicity of allogeneic adipose-derived stem cells in a rat spinal fusion model. Tissue Eng. Part A 2009, 15:2677-2686.
57. Gonzalez M.A., et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009, 136:978-989.
58. Gonzalez-Rey E., et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009, 58:929-939.
59. Wan C.D., et al. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model. Hepatobiliary Pancreat. Dis. Int. 2008, 7:29-33.
60. Prichard H.L., et al. IFATS collection: adipose-derived stromal cells improve the foreign body response. Stem Cells 2008, 26:2691-2695.
61. Constantin G., et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009, 27:2624-2635.
62. Gonzalez M.A., et al. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum. 2009, 60:1006-1019.
63. Gonzalez-Rey E., et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:241-248.
64. Kang S.K., et al. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp. Neurol. 2003, 183:355-366.
65. Dragoo J.L., et al. Bone induction by BMP-2 transduced stem cells derived from human fat. J. Orthop. Res. 2003, 21:622-629.
66. Lu F., et al. Improvement of the survival of human autologous fat transplantation by using VEGF-transfected adipose-derived stem cells. Plast. Reconstr. Surg. 2009, 124:1437-1446.
67. Li H., et al. Adipose tissue-derived mesenchymal stem cell-based liver gene delivery. J. Hepatol. 2011, 54:930-938.
68. Kucerova L., et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007, 67:6304-6313.
69. Muehlberg F.L., et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30:589-597.
70. Vilalta M., et al. Human adipose tissue-derived mesenchymal stromal cells as vehicles for tumor bystander effect: a model based on bioluminescence imaging. Gene Ther. 2009, 16:547-557.
71. Josiah D.T., et al. Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma. Mol. Ther. 2010, 18:377-385.
72. Grisendi G., et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res. 2010, 70:3718-3729.
73. Zolochevska O., et al. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev. 2011, 10.1089/scd.2011.0247.
74. Kim Y.H., et al. Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line. J. Neurooncol. 2012, 106:89-98.
75. Zheng B., et al. Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng. 2006, 12:1891-1901.
76. Yoshimura K., et al. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast. Surg. 2008, 32:48-55. discussion 56-47.
77. Yoon Y.S., et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004, 109:3154-3157.
78. Ning H., et al. The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 2008, 22:593-599.
79. Yu J.M., et al. Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev. 2008, 17:463-473.
80. Kucerova L., et al. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol. Cancer 2010, 9:129.
81. Lin G., et al. Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate 2010, 70:1066-1073.
82. Prantl L., et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate 2010, 70:1709-1715.
83. Pinilla S., et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett. 2009, 284:80-85.
84. Kucerova L., et al. Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells. Neoplasma 2011, 58:361-370.
85. Zimmerlin L., et al. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng. Part A 2011, 17:93-106.
86. Cho J.A., et al. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol. Oncol. 2011, 123:379-386.
87. Cho J.A., et al. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int. J. Oncol. 2012, 40:130-138.
88. McLean K., et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J. Clin. Invest. 2011, 121:3206-3219.
89. Lopez-Iglesias P., et al. Short and long term fate of human AMSC subcutaneously injected in mice. World J. Stem Cells 2011, 3:53-62.
90. Altman A.M., et al. Wound microenvironment sequesters adipose-derived stem cells in a murine model of reconstructive surgery in the setting of concurrent distant malignancy. Plast. Reconstr. Surg. 2011, 127:1467-1477.
91. Ra J.C., et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011, 20:1297-1308.
92. Rada T., et al. Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential. Stem Cell Rev. 2011, 7:64-76.
93. Guilak F., et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J. Cell Physiol. 2006, 206:229-237.
94. Izadpanah R., et al. Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res. 2008, 68:4229-4238.
95. Mikkelsen T.S., et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell 2010, 143:156-169.
96. Tchkonia T., et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E298-E307.
97. Van Harmelen V., et al. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism 2004, 53:632-637.
98. Peptan I.A., et al. Comparison of osteogenic potentials of visceral and subcutaneous adipose-derived cells of rabbits. Plast. Reconstr. Surg. 2006, 117:1462-1470.
99. Tchkonia T., et al. Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 2006, 55:2571-2578.
100. Schulz T.J., et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:143-148.
101. Gealekman O., et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 2011, 123:186-194.
102. Madonna R., et al. Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells. Eur. J. Clin. Invest. 2011, 41:126-133.
103. Zhu M., et al. The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. J. Tissue Eng. Regen. Med. 2009, 3:290-301.
104. Mojallal A., et al. Influence of age and body mass index on the yield and proliferation capacity of adipose-derived stem cells. Aesthetic Plast. Surg. 2011, 35:1097-1105.
105. Shore E.M., Kaplan F.S. Inherited human diseases of heterotopic bone formation. Nat. Rev. Rheumatol. 2010, 6:518-527.